[LGND] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -585.25%
YoY- -149.28%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 27,003 59,590 50,464 38,185 21,192 22,998 14,737 10.61%
PBT -8,175 -56,789 30,665 7,230 5,826 7,012 2,008 -
Tax -810 -14,307 37,675 10,355 -515 279 139 -
NP -7,365 -42,482 -7,010 -3,125 6,341 7,055 1,869 -
Tax Rate - - -122.86% -143.22% 8.84% -3.98% -6.92% -
Total Cost 34,368 102,072 57,474 41,310 14,851 15,943 12,868 17.78%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -27.27 -71.29 -13.89 -8.18 29.92 30.68 12.68 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.43 -2.02 -0.34 -0.15 0.32 0.35 0.09 -
EPS Diluted -0.43 -2.02 -0.33 -0.15 0.29 0.34 0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.